wai yuen tong medicine holdi (897) Snapshot

Wai Yuen Tong Medicine Holdings Ltd. announced that the group is expected to report a turn from a loss to a profit for the full year ended 31 March 2013 as compared to the year ended 31 March 2012. This positive profit alert announcement is only based on the preliminary review on the draft unaudited consolidated management accounts of the group, which are in the course of finalizing and have yet to be confirmed. The board of directors of Wai Yuen Tong Medicine Holdings Limited announced shareholders and potential investors of the company that the group is expected to report a turn from a loss to a profit for the year ended 31 March 2013 as compared to the year ended 31 March 2012. Such improvement in results was mainly attributable to, among other things, the increase in gain on change in fair value of investment properties, the turn from a net realized and unrealized loss to a net realized and unrealized gain on held-for-trading investments and the lack of impairment losses recognized for the investment in an associate as compared to the year ended 31 March 2012.

Wai Yuen Tong Medicine Holdings Ltd., Special/Extraordinary Shareholders Meeting, Mar 07, 2013., at 12:00 China Standard Time. Location: 17/F., Edinburgh Tower, The Landmark. Agenda: To consider the appointment of Ernst & Young as the new auditors of the company and to authorize the board of directors to fix their remuneration; to grant a general mandate to the directors of the company to allot, issue, grant, distribute and deal with the securities in the share capital of the company not exceeding 20% of the issued share capital of the company as at the date of the meeting; to grant a general mandate to the directors to repurchase the securities in the share capital of the company not exceeding 10% of the issued share capital of the company as at the date of the meeting; and to extend, conditional upon the passing of resolutions numbered 2 and 3, the shares and other securities repurchased pursuant to the mandate granted to the directors under the resolution numbered 3 above, to the mandate granted to the directors under the resolution numbered 2.

Wai Yuen Tong Medicine Holdings Ltd. board announced that Deloitte Touche Tohmatsu has tendered their resignation as auditors of the Group with effect from January 28, 2013. The Board shall seek approval of the shareholders of the company at the SGM to appoint Ernst & Young as new auditors of the company to fill the casual vacancy following the resignation of Deloitte and to hold office until the conclusion of the next annual general meeting of the company.